Organoid– tag –
-
Immunotherapy’s Fight Against Cancer: Tumor Organoids and Bioreactors Emerge as Key Research Tools
BioSPX International Overview Immunotherapy fights cancer by empowering immune cells to identify and mount sustained responses against cancer cells, rather than directly targeting tumors with drugs or radiation. Tumor organoids are becom... -
Cerebral Organoids Enter Industrial Era: Automation Drives Standardization and High-Throughput Scaling for Neuroscience Innovation
Newfund Capital USA Overview Cerebral organoid production is undergoing a transformative industrialization, driven by automated platforms for iPSC generation, expansion, and differentiation. This technological leap standardizes manufactu... -
Advances in 3D Bioprinting for Organoid Construction: Enhancing Physiological Relevance and Promoting Diverse Biomedical Applications
PMC (NIH) International Overview A comprehensive review article highlights recent advancements in 3D bioprinting technology for organoid construction. This technique overcomes challenges of traditional organoid culture methods by precise... -
PBS Biotech Joins Organoid COMMONS with Vertical-Wheel® Bioreactor to Accelerate Industrialization and Scalability of Human Organoid Models
PR Newswire (PBS Biotech) USA Overview PBS Biotech has joined Organoid COMMONS to accelerate the industrialization and scalability of human-relevant organoid models. The company contributes its unique Vertical-Wheel® bioreactor platform ... -
Liv Hospital Pioneers iPSC-Driven 3D Bioprinting and Organoid Development, Reshaping Organ Transplantation
Liv Hospital Turkey Overview Liv Hospital is at the forefront of research highlighting the pivotal role of induced pluripotent stem cell (iPSC) lines in advancing 3D bioprinting and organoid development. These initiatives aim to engineer... -
Converging 3D Bioprinting with Organoid Technology Accelerates Precision Medicine and Tissue Engineering
Oxford Academic (Regenerative Biomaterials) UK Overview A recent review highlights the transformative potential of integrating 3D bioprinting with organoid technology, opening new avenues for personalized medicine and advanced tissue eng... -
Converging 3D Bioprinting and Organoids: A Novel Approach Revolutionizing Disease Modeling and Regenerative Medicine
Oxford Academic (Regenerative Biomaterials) Global Overview The convergence of 3D bioprinting and organoid technology presents a new paradigm poised to revolutionize disease modeling, drug screening, and regenerative medicine. 3D bioprin... -
Breakthroughs in iPSC and 3D Organoids Drive Stem Cell Therapies Towards Clinical Reality and Scalable Manufacturing
Academic/Industry Publication Unknown Overview Stem cell therapies are transitioning rapidly from promise to clinical reality, driven by recent advances in iPSC generation and differentiation. Innovative transcription factor mixes now en... -
FBS-Free Glioblastoma Models: A Leap Forward for Reproducibility and Ethical Drug Discovery
MDPI Academic paper Overview A new study successfully evaluates fetal bovine serum (FBS) alternatives for glioblastoma cell culture in advanced biomaterial-based 2D and 3D tumor models, addressing critical ethical and standardization con... -
Global Pluripotent Stem Cell Therapies Progress to 115 Clinical Trials with Over 1,200 Patients, Demonstrating Strong Safety Profile
Vertex AI Search Global Overview Global clinical trials involving pluripotent stem cell therapies have significantly advanced, with 115 trials treating over 1,200 patients by December 2024, reporting no major safety concerns. This progre...
